All but one MARS2 mouse that did not develop ALL went on to develop solid tumors at a time closer to the previously reported latency (median of 266 days) for solid tumors in ARF deficient animals [31]. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.